SA15HG521213
SA15HG521213
Nahdi Medical Co.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 11.82B EUR | 12.09B EUR | 13.66B EUR |
Enterprise Value | 13.06B EUR | 13.7B EUR | 14.32B EUR |
Valuation Multiples | |||
Trailing P/E | 15x | 13.97x | 15.09x |
Forward P/E | 12.89x | -- | -- |
Price to Sales | 1.12x | 1.14x | 1.3x |
Price to Book | 4.7x | 4.81x | 5.22x |
EV/Revenue | 1.24x | 1.29x | 1.36x |
EV/EBITDA | 10.89x | 7.71x | 7.96x |
Price to FCF (P/FCF) | 9.73x | 21.64x | 12.24x |
EV/FCF | 10.76x | 24.53x | 12.82x |
FCF Yield | 10.28% | 4.62% | 8.17% |